Larimar Therapeutics
LRMR
#6458
Rank
HK$4.48 B
Marketcap
HK$61.78
Share price
-12.17%
Change (1 day)
231.03%
Change (1 year)

EPS for Larimar Therapeutics (LRMR)

EPS in 2023 (TTM): -HK$7.21

According to Larimar Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$7.16. In 2022 the company made an earnings per share (EPS) of -HK$11.98 an increase over its 2021 EPS that were of -HK$23.11.

EPS history for Larimar Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$7.21-39.81%
2022-HK$11.98-48.15%
2021-HK$23.11-14.27%
2020-HK$26.96